Register to join the Immune-mediated necrotizing myopathy video support session, the last Saturday of the month at 7 PM...
Register to join the Immune-mediated necrotizing myopathy video support session, the last Saturday of the month at 7 PM...
Register to join the Immune-mediated necrotizing myopathy video support session, the last Saturday of the month at 7 PM...
Register to join the Immune-mediated necrotizing myopathy video support session, the last Saturday of the month at 7 PM...
Register to join the Immune-mediated necrotizing myopathy video support session, the last Saturday of the month at 7 PM...
Register to join the Immune-mediated necrotizing myopathy video support session, the last Saturday of the month at 7 PM...
Register to join the Immune-mediated necrotizing myopathy video support session, the last Saturday of the month at 7 PM...
Introduction to the PRESIDIO Clinical Trial of KZR-616 for the Treatment of Polymyositis and Dermatomyositis
, , Featured, Video
Dr. Mary Katherine (MK) Farmer, MD, Rheumatologist and Senior Medical Director at Kezar Life Sciences, joined us live online...
Introduction to Ra Pharma & the Potential of Zilucoplan for the Treatment of IMNM Webinar
, , Featured, Video
Ben Matys, Sr. Clinical Trial Manager, and Ramin Farzaneh-Far, Chief Medical Officer of Ra Pharma, joined MSU) on November...
A Phase 2 Study of Zilucoplan in Patients with Immune-Mediated Necrotizing Myopathy
, , Featured, Necrotizing Autoimmune Myopathy, News
We are excited to announce our partnership with Ra Pharma for RA101495-02.202: A Phase 2 Study of Zilucoplan in...
Myositis Support and Understanding (MSU) partners with the University of Pittsburgh for a new NIH-sponsored study entitled, “Myositis Patient...
Watch "Polymyositis: The evolution of this diagnosis in light of recent research" with Dr. Christopher-Stine, who also discusses immune-mediated...
